This book gives an overview of pharmacoproteomics and its clinical applications, as well as the latest information on drug mechanisms at the proteome level, the relationship between proteomics and toxicity or resistance, and how proteomics aid in discovery of new drug targets.

Overview of pharmacoproteomics and its clinical applications.- Pharmacoproteomics and precision medicine.- Pharmacoproteomics and drug target discovery.- Analytical methods in pharmacoproteomics.- Bridging the gap between pharmacoproteomics and pharmacogenomics.- Analysis and interpretation of pharmacoproteomic data.- Pharmacoproteomics and sickle cell management.- Pharmacoproteomics and cancer management.- Pharmacoproteomics and neurological disease management.- Pharmacoproteomics and rheumatoid arthritis management.- Proteomics and management of multiple sclerosis.- Biomarker development against infections using proteomics.- Proteomics and COVID-19: recent trends.- Proteomics in the pharmaceutical industry: prospects and challenges.- Nanomaterials in proteomics.- Big data analytics in pharmacoproteomics.- Recent mass spectrometry technologies in pharmacoproteomics.- High throughput pre-clinical models and pharmacoproteomics.

This book gives an overview of pharmacoproteomics and its clinical applications, as well as the latest information on drug mechanisms at the proteome level, the relationship between proteomics and toxicity or resistance, and how proteomics aid in discovery of new drug targets. The book also highlights recent advances in analytical methods, analysis, and interpretation of pharmacoproteomic data. Pharmacoproteomics: Recent Trends and Applications is an ideal book for those working in pharmaceutical industries, as well as scientists, health care professionals, and researchers who work in the field of genomics, pharmacology, pharmacokinetics, toxicology, and pharmaceutical chemistry.

Highlights pharmacoproteomics and precision medicine as well as drug target discovery Discusses recent advances in pharmacoproteomics, future directions, and challenges Provides analytic methods in pharmacoproteomics

GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com